Bruker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bruker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BRKR

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). 

CEO
Frank H. Laukien
CEOFrank H. Laukien
Employees
11,085
Employees11,085
Headquarters
Billerica, Massachusetts
HeadquartersBillerica, Massachusetts
Founded
1960
Founded1960
Employees
11,085
Employees11,085

BRKR Key Statistics

Market cap
8.89B
Market cap8.89B
Price-Earnings ratio
-226.25
Price-Earnings ratio-226.25
Dividend yield
0.37%
Dividend yield0.37%
Average volume
2.34M
Average volume2.34M
High today
$58.49
High today$58.49
Low today
$54.36
Low today$54.36
Open price
$54.65
Open price$54.65
Volume
3.58M
Volume3.58M
52 Week high
$58.49
52 Week high$58.49
52 Week low
$28.53
52 Week low$28.53

Stock Snapshot

As of today, Bruker(BRKR) shares are valued at $58.39. The company's market cap stands at 8.89B, with a P/E ratio of -226.25 and a dividend yield of 36.8%.

On 2026-05-29, Bruker(BRKR) stock moved within a range of $54.36 to $58.49. With shares now at $58.39, the stock is trading +7.4% above its intraday low and -0.2% below the session's peak.

Trading activity shows a volume of 3.58M, compared to an average daily volume of 2.34M.

The stock's 52-week range extends from a low of $28.53 to a high of $58.49.

The stock's 52-week range extends from a low of $28.53 to a high of $58.49.

BRKR News

TipRanks 1h
Bruker participates in a conference call with Jefferies

Life Science Tools & Diagnostics Analyst Peterson, along with Mark Munch, PhD, President of Bruker (BRKR) Nano Group discuss BRKR’s capabilities and positioning...

Simply Wall St 7h
Bruker Valuation Check After BioSpec 18 Tesla MRI Milestone In Neuroscience And Oncology Research

Bruker (BRKR) has drawn fresh attention after commissioning its BioSpec 18 Tesla preclinical MRI system at the Champalimaud Foundation in Lisbon. The high-field...

Bruker Valuation Check After BioSpec 18 Tesla MRI Milestone In Neuroscience And Oncology Research
Simply Wall St 3d
Can Bruker Turn Ultra‑High‑Field MRI Leadership Into Lasting Competitive Moats?

Bruker Corporation recently commissioned its BioSpec 18 Tesla preclinical MRI, the world’s highest-field horizontal-bore system, at the Champalimaud Foundation...

Can Bruker Turn Ultra‑High‑Field MRI Leadership Into Lasting Competitive Moats?

Analyst ratings

64%

of 14 ratings
Buy
64.3%
Hold
28.6%
Sell
7.1%

More BRKR News

TipRanks 3d
Bruker announces commissioning of BioSpec 18 Tesla preclinical MRi

Bruker (BRKR) Corporation announced the commissioning of a novel BioSpec 18 Tesla preclinical MRI at the Champalimaud Foundation in Lisbon, Portugal. The BioSpe...

People also own

Based on the portfolios of people who own BRKR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.